OverviewChartNewsTraderScreen

UNIQURE N.V. EO -,05/  NL0010696654  /

Frankfurt
2024-04-25  8:15:39 AM Chg. -0.2610 Volume Bid9:55:09 PM Ask9:55:09 PM High Low
4.0040EUR -6.12% 0
Turnover: 0.0000		 -Bid Size: - -Ask Size: - 4.0040 4.0040
GlobeNewswire 02-28 uniQure Announces 2023 Financial Results and Highlights Recent Company Progress
GlobeNewswire 01-03 US Neurologists Optimistic Regarding the Huntington’s Disease Treatment Pipeline, Emphasizing Haltin...
GlobeNewswire 2023-12-19 uniQure Announces Update on Phase I/II Clinical Trials of AMT-130 Gene Therapy for the Treatment of ...
GlobeNewswire 2023-12-08 uniQure Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire 2023-11-29 uniQure Announces FDA Clearance of Investigational New Drug Application for AMT-191 Gene Therapy for...
GlobeNewswire 2023-11-15 Mural Oncology Launches to Advance Pipeline of Novel Engineered Cytokine Immunotherapies
GlobeNewswire 2023-11-07 uniQure Announces Third Quarter 2023 Financial Results and Highlights Recent Company Progress
GlobeNewswire 2023-10-24 uniQure Announces Major Presence at the European Society of Gene and Cell Therapy (ESGCT) Annual Mee...
GlobeNewswire 2023-10-05 uniQure Announces Strategic Reorganization to Reduce Operating Expenses and Support Advancement of M...
GlobeNewswire 2023-10-02 uniQure Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire 2023-09-05 uniQure Announces FDA Clearance of Investigational New Drug Application for AMT-260 Gene Therapy for...
GlobeNewswire 2022-03-21 uniQure Announces Completion of Patient Enrollment in the First Two Cohorts of its Phase I/II Clinic...
GlobeNewswire 2022-03-02 Akari Therapeutics Appoints Rachelle Jacques as President and Chief Executive Officer
GlobeNewswire 2022-02-25 uniQure Announces 2021 Financial Results and Highlights Recent Company Progress
GlobeNewswire 2022-02-07 uniQure Announces Dosing of First Patients in European Open-Label Clinical Trial of AMT-130 Gene The...
GlobeNewswire 2021-12-16 uniQure Announces Clinical Update on First Patients in Phase I/II Clinical Trial of AMT-130 Gene The...
GlobeNewswire 2021-12-09 uniQure and CSL Behring Announce Primary Endpoint Achieved in HOPE-B Pivotal Trial of Etranacogene D...
GlobeNewswire 2021-11-10 Spero Therapeutics Announces Third Quarter 2021 Operating Results and Provides Business Update
GlobeNewswire 2021-11-10 Kaleido Biosciences to Appoint Dr. Alison Long as Chief Medical Officer
GlobeNewswire 2021-11-02 uniQure Announces Latest Positive Recommendation from Data Safety Monitoring Board in Phase I/II Cli...
GlobeNewswire 2021-11-01 uniQure to Participate in Upcoming Industry Conferences in November
GlobeNewswire 2021-10-25 uniQure Announces Third Quarter 2021 Financial Results and Highlights Recent Company Progress
GlobeNewswire 2021-10-21 uniQure Announces the Appointment of Rachelle Jacques to its Board of Directors
GlobeNewswire 2021-10-19 uniQure Announces Presentations at the Annual Meeting of The European Society of Gene and Cell Thera...
GlobeNewswire 2021-09-30 uniQure to Participate in Multiple Upcoming Industry Conferences in October